{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T23:07:47Z","timestamp":1792624067239,"version":"4.5.0"},"reference-count":180,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,19]],"date-time":"2023-06-19T00:00:00Z","timestamp":1687132800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100013276","name":"Interreg","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013276","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["CUP E85F21003590001"],"award-info":[{"award-number":["CUP E85F21003590001"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioactive Materials"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.bioactmat.2023.06.013","type":"journal-article","created":{"date-parts":[[2023,6,28]],"date-time":"2023-06-28T09:20:56Z","timestamp":1687944056000},"page":"16-35","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":61,"special_numbering":"C","title":["Mesenchymal stem cell secretome and extracellular vesicles for neurodegenerative diseases: Risk-benefit profile and next steps for the market access"],"prefix":"10.1016","volume":"29","author":[{"given":"Lorella","family":"Giovannelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0241-0620","authenticated-orcid":false,"given":"Elia","family":"Bari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Jommi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fulvio","family":"Tartara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Armocida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Garbossa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Cofano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Luisa","family":"Torre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2331-4339","authenticated-orcid":false,"given":"Lorena","family":"Segale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioactmat.2023.06.013_bib1","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1016\/S1353-8020(09)70122-1","article-title":"Why neurodegenerative diseases are progressive: uncontrolled inflammation drives disease progression","volume":"15","author":"Hong","year":"2009","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.bioactmat.2023.06.013_bib2","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1172\/JCI40543","article-title":"Stem cells in human neurodegenerative disorders - time for clinical translation?","volume":"120","author":"Lindvall","year":"2010","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bioactmat.2023.06.013_bib3","first-page":"41","article-title":"Extracellular vesicles from mesenchymal stem cells exert pleiotropic effects on amyloid-beta, inflammation, and regeneration: a spark of hope for alzheimer's disease from tiny structures?","author":"Elia","year":"2019","journal-title":"Bioessays"},{"key":"10.1016\/j.bioactmat.2023.06.013_bib4","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/ana.23746","article-title":"alpha-Synuclein oligomers and clinical implications for Parkinson disease","volume":"73","author":"Kalia","year":"2013","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bioactmat.2023.06.013_bib5","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2019.00132","article-title":"Neuronal cells rearrangement during aging and neurodegenerative disease: metabolism, oxidative stress and organelles dynamic","volume":"12","author":"Castelli","year":"2019","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.bioactmat.2023.06.013_bib6","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s00441-014-1866-0","article-title":"Calcium signaling in Parkinson's disease","volume":"357","author":"Cali","year":"2014","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.bioactmat.2023.06.013_bib7","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson's disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bioactmat.2023.06.013_bib8","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s00429-011-0347-4","article-title":"alpha-Synuclein in the olfactory system of a mouse model of Parkinson's disease: correlation with olfactory projections","volume":"217","author":"Ubeda-Banon","year":"2012","journal-title":"Brain Struct. Funct."},{"key":"10.1016\/j.bioactmat.2023.06.013_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.736978","article-title":"Alpha-synuclein aggregation in Parkinson's disease","volume":"8","author":"Srinivasan","year":"2021","journal-title":"Front. Med."},{"key":"10.1016\/j.bioactmat.2023.06.013_bib10","doi-asserted-by":"crossref","first-page":"4641","DOI":"10.18632\/aging.102927","article-title":"Effects of the probiotic formulation SLAB51 in in vitro and in vivo Parkinson's disease models","volume":"12","author":"Castelli","year":"2020","journal-title":"Aging-Us"},{"key":"10.1016\/j.bioactmat.2023.06.013_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2019.00122","article-title":"Inflammation, infectious triggers, and Parkinson's disease","volume":"10","author":"Caggiu","year":"2019","journal-title":"Front. Neurol."},{"key":"10.1016\/j.bioactmat.2023.06.013_bib12","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1097\/WCO.0000000000000730","article-title":"Epidemiology of amyotrophic lateral sclerosis: an update of recent literature","volume":"32","author":"Longinetti","year":"2019","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.bioactmat.2023.06.013_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2017.00080","article-title":"ALS pathogenesis and therapeutic approaches: the role of mesenchymal stem cells and extracellular vesicles","volume":"11","author":"Bonafede","year":"2017","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.bioactmat.2023.06.013_bib14","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/s41577-022-00718-z","article-title":"The immunology of multiple sclerosis","volume":"22","author":"Attfield","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bioactmat.2023.06.013_bib15","doi-asserted-by":"crossref","first-page":"100056","DOI":"10.1016\/j.prdoa.2020.100056","article-title":"Huntington disease: advances in the understanding of its mechanisms","volume":"3","author":"Gatto","year":"2020","journal-title":"Clin.Parkinsonism Relat. Disord."},{"key":"10.1016\/j.bioactmat.2023.06.013_bib16","unstructured":"A. Ajitkumar, O. De Jesus, Huntington Disease in: T.I.F.S. Publishing, Jan-. (Eds.) In: StatPearls [Internet]. , https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK559166\/, Updated 2022 Oct 7."},{"key":"10.1016\/j.bioactmat.2023.06.013_bib17","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/01376517-200710000-00005","article-title":"Acute ischemic stroke review","volume":"39","author":"Hinkle","year":"2007","journal-title":"J. Neurosci. Nurs. : J. Am. Associat.Neurosci. Nurse"},{"key":"10.1016\/j.bioactmat.2023.06.013_bib18","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/j.1747-4949.2011.00666.x","article-title":"Can stroke cause neurodegenerative dementia?","volume":"6","author":"Cumming","year":"2011","journal-title":"Int. J. Stroke"},{"key":"10.1016\/j.bioactmat.2023.06.013_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0079-6123(05)52034-X","article-title":"Autonomic dysfunction in spinal cord injury: clinical presentation of symptoms and signs","volume":"152","author":"Karlsson","year":"2006","journal-title":"Autonomic Dysfunct. Spinal Cord Injury"},{"key":"10.1016\/j.bioactmat.2023.06.013_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2019.00282","article-title":"Traumatic spinal cord injury: an overview of pathophysiology, models and acute injury mechanisms","volume":"10","author":"Alizadeh","year":"2019","journal-title":"Front. Neurol."},{"key":"10.1016\/j.bioactmat.2023.06.013_bib21","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/s41582-019-0244-7","article-title":"Ageing as a risk factor for neurodegenerative disease","volume":"15","author":"Hou","year":"2019","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.bioactmat.2023.06.013_bib22","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.jalz.2018.02.001","article-title":"Alzheimer's disease facts and figures","volume":"14","author":"Alzheimer's","year":"2018","journal-title":"Alzheimer's Dementia"},{"key":"10.1016\/j.bioactmat.2023.06.013_bib23","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/S0140-6736(17)33185-9","article-title":"Global and regional economic costs of dementia: a systematic review","volume":"390","author":"Xu","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.bioactmat.2023.06.013_bib24","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/s41582-020-0377-8","article-title":"Applications of machine learning to diagnosis and treatment of neurodegenerative diseases","volume":"16","author":"Myszczynska","year":"2020","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.bioactmat.2023.06.013_bib25","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.591065","article-title":"Immunomodulatory and regenerative effects of mesenchymal stem cells and extracellular vesicles: therapeutic outlook for inflammatory and degenerative diseases","volume":"11","author":"Dabrowska","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bioactmat.2023.06.013_bib26","unstructured":"A. Karimian, S.M. Khoshnazar, T. Kazemi, A. Asadi, A. Abdolmaleki, Role of secretomes in cell-free therapeutic strategies in regenerative medicine, Cell Tissue Bank.."},{"key":"10.1016\/j.bioactmat.2023.06.013_bib27","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jconrel.2019.07.022","article-title":"Mesenchymal stem\/stromal cell secretome for lung regeneration: the long way through \"pharmaceuticalization\" for the best formulation","volume":"309","author":"Bari","year":"2019","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.bioactmat.2023.06.013_bib28","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.mayocp.2019.01.001","article-title":"Mesenchymal stromal cell therapies for neurodegenerative diseases","volume":"94","author":"Staff","year":"2019","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.bioactmat.2023.06.013_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejcb.2020.151097","article-title":"Mesenchymal stromal cells (MSCs) for neurodegenerative disease: a promising frontier","volume":"99","author":"Shariati","year":"2020","journal-title":"Eur. J. Cell Biol."},{"key":"10.1016\/j.bioactmat.2023.06.013_bib30","article-title":"Overcoming gaps in the treatment of neurodegenerative disease","volume":"60","year":"2020","journal-title":"EBioMedicine"},{"key":"10.1016\/j.bioactmat.2023.06.013_bib31","doi-asserted-by":"crossref","DOI":"10.3390\/cells8080784","article-title":"Mesenchymal stem cell migration and tissue repair","volume":"8","author":"Fu","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.bioactmat.2023.06.013_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0137255","article-title":"Human mesenchymal stem cells retain multilineage differentiation capacity including neural marker expression after extended in vitro expansion","volume":"10","author":"Okolicsanyi","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.bioactmat.2023.06.013_bib33","article-title":"Role of human mesenchymal stem cells in regenerative therapy","volume":"10","author":"Vasanthan","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.bioactmat.2023.06.013_bib34","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.tips.2020.06.009","article-title":"Mesenchymal stem cell immunomodulation: mechanisms and therapeutic potential","volume":"41","author":"Song","year":"2020","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bioactmat.2023.06.013_bib35","doi-asserted-by":"crossref","DOI":"10.1186\/s40035-020-00199-x","article-title":"Transplantation of bone marrow mesenchymal stem cells improves cognitive deficits and alleviates neuropathology in animal models of Alzheimer's disease: a meta-analytic review on potential mechanisms","volume":"9","author":"Qin","year":"2020","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.bioactmat.2023.06.013_bib36","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1089\/scd.2015.0127","article-title":"A meta-analysis of mesenchymal stem cells in animal models of Parkinson's disease","volume":"24","author":"Riecke","year":"2015","journal-title":"Stem Cell. Dev."},{"key":"10.1016\/j.bioactmat.2023.06.013_bib37","doi-asserted-by":"crossref","first-page":"3637","DOI":"10.1007\/s10072-020-05036-7","article-title":"Preclinical studies of mesenchymal stem cells transplantation in amyotrophic lateral sclerosis: a systemic review and metaanalysis","volume":"42","author":"Zhou","year":"2021","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.bioactmat.2023.06.013_bib38","first-page":"44","article-title":"Mesenchymal stem cells in experimental autoimmune encephalomyelitis model of multiple sclerosis: a systematic review and meta-analysis","author":"Yang","year":"2020","journal-title":"Multiple Sclerosis Relat. Disord."},{"key":"10.1016\/j.bioactmat.2023.06.013_bib39","first-page":"1634","article-title":"Neuroprotective effect of stem cell transplantation on cerebral ischemia-reperfusion injury in rats: a systematic review","volume":"27","author":"Li","year":"2023","journal-title":"Chin. J.Tissue Eng. Res."},{"key":"10.1016\/j.bioactmat.2023.06.013_bib40","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.jcyt.2020.09.007","article-title":"Current evidence on mesenchymal stem cell therapy for traumatic spinal cord injury: systematic review and meta-analysis","volume":"23","author":"Muthu","year":"2021","journal-title":"Cytotherapy"},{"key":"10.1016\/j.bioactmat.2023.06.013_bib41","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.trci.2015.06.007","article-title":"Stereotactic brain injection of human umbilical cord blood mesenchymal stem cells in patients with Alzheimer's disease dementia: a phase 1 clinical trial","volume":"1","author":"Kim","year":"2015","journal-title":"Alzheimer's Dementia"},{"key":"10.1016\/j.bioactmat.2023.06.013_bib42","doi-asserted-by":"crossref","DOI":"10.1186\/s13195-021-00897-2","article-title":"Intracerebroventricular injection of human umbilical cord blood mesenchymal stem cells in patients with Alzheimer's disease dementia: a phase I clinical trial","volume":"13","author":"Kim","year":"2021","journal-title":"Alzheimer's Res. Ther."},{"key":"10.1016\/j.bioactmat.2023.06.013_bib43","first-page":"592","article-title":"Safety, feasibility of intravenous and intrathecal injection of autologous bone marrow derived mesenchymal stromal cells in patients with amyotrophic lateral sclerosis: an open label phase I clinical trial","volume":"20","author":"Nabavi","year":"2019","journal-title":"Cell J."},{"key":"10.1016\/j.bioactmat.2023.06.013_bib44","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1001\/jamaneurol.2015.4321","article-title":"Safety and clinical effects of mesenchymal stem cells secreting neurotrophic factor transplantation in patients with amyotrophic lateral sclerosis results of phase 1\/2 and 2a clinical trials","volume":"73","author":"Petrou","year":"2016","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.bioactmat.2023.06.013_bib45","doi-asserted-by":"crossref","first-page":"647","DOI":"10.3727\/096368916X693716","article-title":"Transplantation of mesenchymal stromal cells in patients with amyotrophic lateral sclerosis: results of phase I\/IIa clinical trial","volume":"26","author":"Sykova","year":"2017","journal-title":"Cell Transplant."},{"key":"10.1016\/j.bioactmat.2023.06.013_bib46","doi-asserted-by":"crossref","first-page":"693","DOI":"10.52586\/4980","article-title":"A phase II clinical trial with repeated intrathecal injections of autologous mesenchymal stem cells in patients with amyotrophic lateral sclerosis","volume":"26","author":"Petrou","year":"2021","journal-title":"Front. Biosci.Landm."},{"key":"10.1016\/j.bioactmat.2023.06.013_bib47","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S1474-4422(11)70305-2","article-title":"Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study","volume":"11","author":"Connick","year":"2012","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.bioactmat.2023.06.013_bib48","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1177\/1352458517703802","article-title":"Pilot trial of intravenous autologous culture-expanded mesenchymal stem cell transplantation in multiple sclerosis","volume":"24","author":"Cohen","year":"2018","journal-title":"Multip.Sclerosis J."},{"key":"10.1016\/j.bioactmat.2023.06.013_bib49","doi-asserted-by":"crossref","DOI":"10.1186\/s12967-021-02869-4","article-title":"Clinical feasibility of umbilical cord tissue-derived mesenchymal stem cells in the treatment of multiple sclerosis (vol 16, 57, 2018)","volume":"19","author":"Riordan","year":"2021","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.bioactmat.2023.06.013_bib50","doi-asserted-by":"crossref","first-page":"3574","DOI":"10.1093\/brain\/awaa333","article-title":"Beneficial effects of autologous mesenchymal stem cell transplantation in active progressive multiple sclerosis","volume":"143","author":"Petrou","year":"2020","journal-title":"Brain"},{"key":"10.1016\/j.bioactmat.2023.06.013_bib51","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1001\/archneurol.2010.248","article-title":"Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis","volume":"67","author":"Karussis","year":"2010","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.bioactmat.2023.06.013_bib52","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.639315","article-title":"Long-term clinical and immunological effects of repeated mesenchymal stem cell injections in patients with progressive forms of multiple sclerosis","volume":"12","author":"Petrou","year":"2021","journal-title":"Front. Neurol."},{"key":"10.1016\/j.bioactmat.2023.06.013_bib53","doi-asserted-by":"crossref","first-page":"729","DOI":"10.3727\/096368913X664540","article-title":"Autologous bone marrow-derived cell therapy combined with physical therapy induces functional improvement in chronic spinal cord injury patients","volume":"23","author":"El-kheir","year":"2014","journal-title":"Cell Transplant."},{"key":"10.1016\/j.bioactmat.2023.06.013_bib54","article-title":"Safety and neurological assessments after autologous transplantation of bone marrow mesenchymal stem cells in subjects with chronic spinal cord injury","volume":"5","author":"Pinheiro Mendonca","year":"2014","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.bioactmat.2023.06.013_bib55","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.jcyt.2016.01.004","article-title":"Autologous mesenchymal stromal cell transplantation for spinal cord injury: a Phase I pilot study","volume":"18","author":"Satti","year":"2016","journal-title":"Cytotherapy"},{"key":"10.1016\/j.bioactmat.2023.06.013_bib56","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.3727\/096368908787648074","article-title":"Administration of autologous bone marrow stem cells into spinal cord injury patients via multiple routes is safe and improves their quality of life: comprehensive case studies","volume":"17","author":"Geffner","year":"2008","journal-title":"Cell Transplant."},{"key":"10.1016\/j.bioactmat.2023.06.013_bib57","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jcyt.2020.08.008","article-title":"Clinical effects of intrathecal administration of expanded Wharton jelly mesenchymal stromal cells in patients with chronic complete spinal cord injury: a randomized controlled study","volume":"23","author":"Albu","year":"2021","journal-title":"Cytotherapy"},{"key":"10.1016\/j.bioactmat.2023.06.013_bib58","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.mayocp.2019.10.008","article-title":"CELLTOP clinical trial: first report from a phase 1 trial of autologous adipose tissue-derived mesenchymal stem cells in the treatment of paralysis due to traumatic spinal cord injury","volume":"95","author":"Bydon","year":"2020","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.bioactmat.2023.06.013_bib59","doi-asserted-by":"crossref","DOI":"10.1186\/s13287-021-02609-x","article-title":"The safety of MSC therapy over the past 15 years: a meta-analysis","volume":"12","author":"Wang","year":"2021","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.bioactmat.2023.06.013_bib60","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/jor.1100090504","article-title":"Mesenchymal stem-cells","volume":"9","author":"Caplan","year":"1991","journal-title":"J. Orthop. Res."},{"key":"10.1016\/j.bioactmat.2023.06.013_bib61","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.stem.2011.06.008","article-title":"The MSC: an injury drugstore","volume":"9","author":"Caplan","year":"2011","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.bioactmat.2023.06.013_bib62","doi-asserted-by":"crossref","DOI":"10.3390\/cells7110190","article-title":"Pilot production of mesenchymal stem\/stromal freeze-dried secretome for cell-free regenerative nanomedicine: a validated GMP-compliant process","volume":"7","author":"Bari","year":"2018","journal-title":"Cells"},{"key":"10.1016\/j.bioactmat.2023.06.013_bib63","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22020845","article-title":"Comparative proteomic analysis of the mesenchymal stem cells secretome from adipose, bone marrow, placenta and wharton's jelly","volume":"22","author":"Shin","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioactmat.2023.06.013_bib64","doi-asserted-by":"crossref","first-page":"753","DOI":"10.2217\/nnm-2018-0240","article-title":"Freeze-dried and GMP-compliant pharmaceuticals containing exosomes for acellular mesenchymal stromal cell immunomodulant therapy","volume":"14","author":"Bari","year":"2019","journal-title":"Nanomedicine"},{"key":"10.1016\/j.bioactmat.2023.06.013_bib65","first-page":"11","article-title":"Integrated analysis of transcriptome and secretome from umbilical cord mesenchymal stromal cells reveal new mechanisms for the modulation of inflammation and immune activation","author":"Cruz-Barrera","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bioactmat.2023.06.013_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejpb.2020.08.003","article-title":"GMP-compliant sponge-like dressing containing MSC lyo-secretome: proteomic network of healing in a murine wound model","author":"Bari","year":"2020","journal-title":"Eur. J. Pharm. Biopharm. : Off.J. Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V"},{"key":"10.1016\/j.bioactmat.2023.06.013_bib67","article-title":"Secretome analysis of mesenchymal stem cell factors fostering oligodendroglial differentiation of neural stem cells in vivo","volume":"21","author":"Agrelo","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioactmat.2023.06.013_bib68","first-page":"8","article-title":"Adipose mesenchymal extracellular vesicles as alpha-1-antitrypsin physiological delivery systems for lung regeneration","author":"Bari","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.bioactmat.2023.06.013_bib69","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.ebiom.2019.07.009","article-title":"Functional secretome analysis reveals Annexin-A1 as important paracrine factor derived from fetal mesenchymal stem cells in hepatic regeneration","volume":"45","author":"Zagoura","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.bioactmat.2023.06.013_bib70","doi-asserted-by":"crossref","first-page":"553","DOI":"10.3390\/ph14060553","article-title":"Equine mesenchymal stem\/stromal cells freeze-dried secretome (lyosecretome) for the treatment of musculoskeletal diseases: production process validation and batch release test for clinical use","volume":"14","author":"Mocchi","year":"2021","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.bioactmat.2023.06.013_bib71","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/jcp.21701","article-title":"Secretome from mesenchymal stem cells induces angiogenesis via Cyr61","volume":"219","author":"Estrada","year":"2009","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.bioactmat.2023.06.013_bib72","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.pharmthera.2014.02.013","article-title":"Mesenchymal stem\/stromal cells as a pharmacological and therapeutic approach to accelerate angiogenesis","volume":"143","author":"Bronckaers","year":"2014","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bioactmat.2023.06.013_bib73","article-title":"Angiogenesis in newly regenerated bone by secretomes of human mesenchymal stem cells","volume":"39","author":"Katagiri","year":"2017","journal-title":"Maxillof. Plast. Reconstruct. Surg."},{"key":"10.1016\/j.bioactmat.2023.06.013_bib74","article-title":"Paracrine mechanisms of mesenchymal stromal cells in angiogenesis","volume":"2020","author":"Maacha","year":"2020","journal-title":"Stem Cell. Int."},{"key":"10.1016\/j.bioactmat.2023.06.013_bib75","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.imlet.2015.06.007","article-title":"The secretome of mesenchymal stromal cells: role of extracellular vesicles in immunomodulation","volume":"168","author":"Bruno","year":"2015","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.bioactmat.2023.06.013_bib76","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2017.00220","article-title":"Mesenchymal stem cells secretory responses: senescence messaging secretome and immunomodulation perspective","volume":"8","author":"Lunyak","year":"2017","journal-title":"Front. Genet."},{"key":"10.1016\/j.bioactmat.2023.06.013_bib77","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/978-1-4939-3584-0_7","article-title":"Paracrine mechanisms of mesenchymal stem cells in tissue repair","volume":"1416","author":"Gnecchi","year":"2016","journal-title":"Mesenchymal Stem Cells, 2 Ed.: Method. Protocol."},{"key":"10.1016\/j.bioactmat.2023.06.013_bib78","doi-asserted-by":"crossref","first-page":"5979","DOI":"10.7150\/thno.40122","article-title":"Mesenchymal stromal\/stem cell-derived extracellular vesicles in tissue repair: challenges and opportunities","volume":"10","author":"Varderidou-Minasian","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.bioactmat.2023.06.013_bib79","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cytogfr.2019.04.002","article-title":"The mesenchymal stem cell secretome: a new paradigm towards cell-free therapeutic mode in regenerative medicine","volume":"46","author":"Kumar","year":"2019","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.bioactmat.2023.06.013_bib80","doi-asserted-by":"crossref","first-page":"75","DOI":"10.4103\/1673-5374.264455","article-title":"Mesenchymal stem cells secretome: current trends and future challenges","volume":"15","author":"Teixeira","year":"2020","journal-title":"Neural Regenerat. Res."},{"key":"10.1016\/j.bioactmat.2023.06.013_bib81","first-page":"9","article-title":"Mesenchymal stromal cell secretome for severe COVID-19 infections: premises for the therapeutic use","author":"Bari","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.bioactmat.2023.06.013_bib82","first-page":"10","article-title":"Mesenchymal stromal cell secretome for post-COVID-19 pulmonary fibrosis: a new therapy to treat the long-term lung sequelae?","author":"Bari","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.bioactmat.2023.06.013_bib83","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.3233\/JAD-170848","article-title":"Mesenchymal stem cell-derived extracellular vesicles suppresses iNOS expression and ameliorates neural impairment in alzheimer's disease mice","volume":"61","author":"Wang","year":"2018","journal-title":"J. Alzheim. Dis."},{"key":"10.1016\/j.bioactmat.2023.06.013_bib84","first-page":"8","article-title":"Intracerebral injection of extracellular vesicles from mesenchymal stem cells exerts reduced A beta plaque burden in early stages of a preclinical model of alzheimer's disease","author":"Elia","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.bioactmat.2023.06.013_bib85","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.4103\/1673-5374.255978","article-title":"Mesenchymal stem cell-derived exosomes promote neurogenesis and cognitive function recovery in a mouse model of Alzheimer's disease","volume":"14","author":"Reza-Zaldivar","year":"2019","journal-title":"Neural Regenerat. Res."},{"key":"10.1016\/j.bioactmat.2023.06.013_bib86","doi-asserted-by":"crossref","first-page":"15285","DOI":"10.18632\/aging.203088","article-title":"Mesenchymal stem cells-derived extracellular vesicles ameliorate Alzheimer's disease in rat models via the microRNA-29c-3p\/BACE1 axis and the Wnt\/beta-catenin pathway","volume":"13","author":"Sha","year":"2021","journal-title":"Aging-Us"},{"key":"10.1016\/j.bioactmat.2023.06.013_bib87","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1096\/fj.201700600R","article-title":"Exosomes derived from hypoxia-preconditioned mesenchymal stromal cells ameliorate cognitive decline by rescuing synaptic dysfunction and regulating inflammatory responses in APP\/PS1 mice","volume":"32","author":"Cui","year":"2018","journal-title":"Faseb. J."},{"key":"10.1016\/j.bioactmat.2023.06.013_bib88","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1007\/s11064-018-2641-5","article-title":"Exosomes isolated from human umbilical cord mesenchymal stem cells alleviate neuroinflammation and reduce amyloid-beta deposition by modulating microglial activation in alzheimer's disease","volume":"43","author":"Ding","year":"2018","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.bioactmat.2023.06.013_bib89","doi-asserted-by":"crossref","DOI":"10.1186\/s12979-019-0150-2","article-title":"RVG-modified exosomes derived from mesenchymal stem cells rescue memory deficits by regulating inflammatory responses in a mouse model of Alzheimer's disease","volume":"16","author":"Cui","year":"2019","journal-title":"Immun. Ageing"},{"key":"10.1016\/j.bioactmat.2023.06.013_bib90","article-title":"Mesenchymal stem cell-derived exosomes ameliorate alzheimer's disease pathology and improve cognitive deficits","volume":"9","author":"Chen","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.bioactmat.2023.06.013_bib91","doi-asserted-by":"crossref","DOI":"10.1038\/s41420-021-00620-y","article-title":"Tail-vein injection of MSC-derived small extracellular vesicles facilitates the restoration of hippocampal neuronal morphology and function in APP\/PS1 mice","volume":"7","author":"Wang","year":"2021","journal-title":"Cell Death Discover."},{"key":"10.1016\/j.bioactmat.2023.06.013_bib92","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1002\/sctm.19-0327","article-title":"Intranasal delivery of mesenchymal stem cell-derived extracellular vesicles exerts immunomodulatory and neuroprotective effects in a 3xTg model of Alzheimer's disease","volume":"9","author":"Losurdo","year":"2020","journal-title":"Stem Cells Translat. Med."},{"key":"10.1016\/j.bioactmat.2023.06.013_bib93","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.jconrel.2020.09.019","article-title":"ADSCs-derived extracellular vesicles alleviate neuronal damage, promote neurogenesis and rescue memory loss in mice with Alzheimer's disease","volume":"327","author":"Ma","year":"2020","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.bioactmat.2023.06.013_bib94","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/s41418-020-0592-2","article-title":"Intranasal delivery of mesenchymal stem cell secretome repairs the brain of Alzheimer's mice","volume":"28","author":"Santamaria","year":"2021","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.bioactmat.2023.06.013_bib95","doi-asserted-by":"crossref","first-page":"8129","DOI":"10.7150\/thno.62069","article-title":"Mesenchymal stem cell-derived extracellular vesicles ameliorate Alzheimer's disease-like phenotypes in a preclinical mouse model","volume":"11","author":"Cone","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.bioactmat.2023.06.013_bib96","first-page":"383796","article-title":"The Alzheimer's amyloid-degrading peptidase, neprilysin: can we control it?","volume":"2012","author":"Nalivaeva","year":"2012","journal-title":"Int. J. Alzheimer's Dis."},{"key":"10.1016\/j.bioactmat.2023.06.013_bib97","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2019.101283","article-title":"Oxidative inactivation of amyloid beta-degrading proteases by cholesterol-enhanced mitochondrial stress","volume":"26","author":"de Dios","year":"2019","journal-title":"Redox Biol."},{"key":"10.1016\/j.bioactmat.2023.06.013_bib98","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/72237","article-title":"Identification of the major A beta(1-42)-degrading catabolic pathway in brain parenchyma: suppression leads to biochemical and pathological deposition","volume":"6","author":"Iwata","year":"2000","journal-title":"Nat. Med."},{"key":"10.1016\/j.bioactmat.2023.06.013_bib99","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.2174\/092986707780597961","article-title":"Microglial activation and its implications in the brain diseases","volume":"14","author":"Dheen","year":"2007","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.bioactmat.2023.06.013_bib100","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1179\/016164104225016236","article-title":"Nitric oxide pathways in Alzheimer's disease and other neurodegenerative dementias","volume":"26","author":"Togo","year":"2004","journal-title":"Neurol. Res."},{"key":"10.1016\/j.bioactmat.2023.06.013_bib101","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.3727\/096368915X689938","article-title":"Combined MSC-secreted factors and neural stem cell transplantation promote functional recovery of PD rats","volume":"25","author":"Yao","year":"2016","journal-title":"Cell Transplant."},{"key":"10.1016\/j.bioactmat.2023.06.013_bib102","doi-asserted-by":"crossref","first-page":"634","DOI":"10.5966\/sctm.2016-0071","article-title":"Impact of the secretome of human mesenchymal stem cells on brain structure and animal behavior in a rat model of Parkinson's disease","volume":"6","author":"Teixeira","year":"2017","journal-title":"Stem Cells Translat. Med."},{"key":"10.1016\/j.bioactmat.2023.06.013_bib103","first-page":"11","article-title":"Exosomes derived from mesenchymal stem cells repair a Parkinson's disease model by inducing autophagy","author":"Chen","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bioactmat.2023.06.013_bib104","first-page":"9","article-title":"Preclinical comparison of stem cells secretome and levodopa application in a 6-hydroxydopamine rat model of Parkinson's disease","author":"Teixeira","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.bioactmat.2023.06.013_bib105","doi-asserted-by":"crossref","first-page":"915","DOI":"10.2217\/rme-2021-0018","article-title":"Neuroprotective effect of bone marrow derived mesenchymal stem cell secretome in 6-OHDA-induced Parkinson's disease","volume":"16","author":"Mahendru","year":"2021","journal-title":"Regen. Med."},{"key":"10.1016\/j.bioactmat.2023.06.013_bib106","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.14336\/AD.2020.1221","article-title":"MSC-derived exosomes can enhance the angiogenesis of human brain MECs and show therapeutic potential in a mouse model of Parkinson's disease","volume":"12","author":"Xue","year":"2021","journal-title":"Aging Dis."},{"key":"10.1016\/j.bioactmat.2023.06.013_bib107","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2020.105218","article-title":"Exosome-mediated delivery of antisense oligonucleotides targeting alpha-synuclein ameliorates the pathology in a mouse model of Parkinson's disease","volume":"148","author":"Yang","year":"2021","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bioactmat.2023.06.013_bib108","first-page":"771","article-title":"Exosomes isolated during dopaminergic neuron differentiation suppressed neuronal inflammation in a rodent model of Parkinson's disease","author":"Li","year":"2022","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bioactmat.2023.06.013_bib109","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1093\/jnen\/nlac037","article-title":"Bone marrow-derived mesenchymal stem cell-derived exosomes containing Gli1 alleviate microglial activation and neuronal apoptosis in vitro and in a mouse Parkinson disease model by direct inhibition of Sp1 signaling","volume":"81","author":"Cai","year":"2022","journal-title":"JNEN (J. Neuropathol. Exp. Neurol.)"},{"key":"10.1016\/j.bioactmat.2023.06.013_bib110","doi-asserted-by":"crossref","DOI":"10.1038\/s41420-022-00823-x","article-title":"MicroRNA-181a-2-3p shuttled by mesenchymal stem cell-secreted extracellular vesicles inhibits oxidative stress in Parkinson's disease by inhibiting EGR1 and NOX4","volume":"8","author":"Ma","year":"2022","journal-title":"Cell Death Discover."},{"key":"10.1016\/j.bioactmat.2023.06.013_bib111","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1021\/acsnano.1c08473","article-title":"Intranasal administration of self-oriented nanocarriers based on therapeutic exosomes for synergistic treatment of Parkinson's disease","volume":"16","author":"Peng","year":"2022","journal-title":"ACS Nano"},{"key":"10.1016\/j.bioactmat.2023.06.013_bib112","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.brainres.2008.06.087","article-title":"Implantation of human umbilical cord-derived mesenchymal stem cells as a neuroprotective therapy for ischemic stroke in rats","volume":"1229","author":"Koh","year":"2008","journal-title":"Brain Res."},{"key":"10.1016\/j.bioactmat.2023.06.013_bib113","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21103651","article-title":"ASC-exosomes ameliorate the disease progression in SOD1(g93a) murine model underlining their potential therapeutic use in human ALS","volume":"21","author":"Bonafede","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioactmat.2023.06.013_bib114","doi-asserted-by":"crossref","first-page":"167","DOI":"10.30574\/ijsra.2021.2.2.0058","article-title":"Treating amyotrophic lateral sclerosis with a bone marrow derived mesenchymal stem cell extracellular vesicles - a case report","volume":"2","author":"Crose","year":"2021","journal-title":"Int. J.Sci.Res. Archiv."},{"key":"10.1016\/j.bioactmat.2023.06.013_bib115","article-title":"The first in human case of amyotrophic lateral sclerosis treated with stem CellDerived conditioned medium: a 1-year- follow up","volume":"4","author":"Ueda","year":"2022","journal-title":"Neurol. Neurorehabilit."},{"key":"10.1016\/j.bioactmat.2023.06.013_bib116","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1177\/0394632017722332","article-title":"Human periodontal ligament stem cells secretome from multiple sclerosis patients suppresses NALP3 inflammasome activation in experimental autoimmune encephalomyelitis","volume":"30","author":"Rajan","year":"2017","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"10.1016\/j.bioactmat.2023.06.013_bib117","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-25676-2","article-title":"Nanovesicles from adipose-derived mesenchymal stem cells inhibit T lymphocyte trafficking and ameliorate chronic experimental autoimmune encephalomyelitis","volume":"8","author":"Farinazzo","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioactmat.2023.06.013_bib118","first-page":"8","article-title":"Placental mesenchymal stem cell-derived extracellular vesicles promote myelin regeneration in an animal model of multiple sclerosis","author":"Clark","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.bioactmat.2023.06.013_bib119","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jconrel.2019.02.032","article-title":"Immunomodulatory properties of MSC-derived exosomes armed with high affinity aptamer toward mylein as a platform for reducing multiple sclerosis clinical score","volume":"299","author":"Shamili","year":"2019","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.bioactmat.2023.06.013_bib120","doi-asserted-by":"crossref","first-page":"8779","DOI":"10.1002\/jcp.29721","article-title":"Therapeutic effects of extracellular vesicles from human adipose-derived mesenchymal stem cells on chronic experimental autoimmune encephalomyelitis","volume":"235","author":"Jafarinia","year":"2020","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.bioactmat.2023.06.013_bib121","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.107207","article-title":"Intranasal administration of small extracellular vesicles derived from mesenchymal stem cells ameliorated the experimental autoimmune encephalomyelitis","volume":"90","author":"Fathollahi","year":"2021","journal-title":"Int. Immunopharm."},{"key":"10.1016\/j.bioactmat.2023.06.013_bib122","article-title":"Human umbilical cord mesenchymal stem cell-derived extracellular vesicles attenuate experimental autoimmune encephalomyelitis via regulating pro and anti-inflammatory cytokines","volume":"11","author":"Koohsari","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioactmat.2023.06.013_bib123","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2021.113895","article-title":"Exosomes derived from bone marrow mesenchymal stromal cells promote remyelination and reduce neuroinflammation in the demyelinating central nervous system","volume":"347","author":"Zhang","year":"2022","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.bioactmat.2023.06.013_bib124","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.intimp.2018.12.001","article-title":"Exosomes derived from mesenchymal stem cells attenuate inflammation and demyelination of the central nervous system in EAE rats by regulating the polarization of microglia","volume":"67","author":"Li","year":"2019","journal-title":"Int. Immunopharm."},{"key":"10.1016\/j.bioactmat.2023.06.013_bib125","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.972247","article-title":"Mesenchymal stromal cell extracellular vesicles for multiple sclerosis in preclinical rodent models: a meta-analysis","volume":"13","author":"Xun","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bioactmat.2023.06.013_bib126","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1111\/jcmm.14113","article-title":"Conditioned medium from amniotic cells protects striatal degeneration and ameliorates motor deficits in the R6\/2 mouse model of Huntington's disease","volume":"23","author":"Giampa","year":"2019","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.bioactmat.2023.06.013_bib127","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1038\/jcbfm.2013.152","article-title":"Systemic administration of exosomes released from mesenchymal stromal cells promote functional recovery and neurovascular plasticity after stroke in rats","volume":"33","author":"Xin","year":"2013","journal-title":"J. Cerebr. Blood Flow Metabol."},{"key":"10.1016\/j.bioactmat.2023.06.013_bib128","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.5966\/sctm.2015-0078","article-title":"Extracellular vesicles improve post-stroke neuroregeneration and prevent postischemic immunosuppression","volume":"4","author":"Doeppner","year":"2015","journal-title":"Stem Cells Translat. Med."},{"key":"10.1016\/j.bioactmat.2023.06.013_bib129","doi-asserted-by":"crossref","first-page":"74537","DOI":"10.18632\/oncotarget.12902","article-title":"Intravenous administration of xenogenic adipose-derived mesenchymal stem cells (ADMSC) and ADMSC-derived exosomes markedly reduced brain infarct volume and preserved neurological function in rat after acute ischemic stroke","volume":"7","author":"Chen","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.bioactmat.2023.06.013_bib130","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1161\/STROKEAHA.116.015204","article-title":"MicroRNA cluster miR-17-92 cluster in exosomes enhance neuroplasticity and functional recovery after stroke in rats","volume":"48","author":"Xin","year":"2017","journal-title":"Stroke"},{"key":"10.1016\/j.bioactmat.2023.06.013_bib131","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.yexcr.2018.08.021","article-title":"Exosomes derived from PEDF modified adipose-derived mesenchymal stem cells ameliorate cerebral ischemia-reperfusion injury by regulation of autophagy and apoptosis","volume":"371","author":"Huang","year":"2018","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.bioactmat.2023.06.013_bib132","first-page":"780","article-title":"Exosomes from miRNA-126-modified ADSCs promotes functional recovery after stroke in rats by improving neurogenesis and suppressing microglia activation","volume":"11","author":"Geng","year":"2019","journal-title":"Am. J. Tourism Res."},{"key":"10.1016\/j.bioactmat.2023.06.013_bib133","article-title":"Rapid enkephalin delivery using exosomes to promote neurons recovery in ischemic stroke by inhibiting neuronal p53\/caspase-3","volume":"2019","author":"Liu","year":"2019","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.bioactmat.2023.06.013_bib134","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s12975-018-0668-1","article-title":"Application of mesenchymal stem cell-derived extracellular vesicles for stroke: biodistribution and MicroRNA study","volume":"10","author":"Moon","year":"2019","journal-title":"Translat. Stroke Res."},{"key":"10.1016\/j.bioactmat.2023.06.013_bib135","article-title":"Microvesicles from brain-extract-treated mesenchymal stem cells improve neurological functions in a rat model of ischemic stroke","volume":"6","author":"Lee","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioactmat.2023.06.013_bib136","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1159\/000490078","article-title":"Exosomes from MiR-30d-5p-ADSCs reverse acute ischemic stroke-induced, autophagy-mediated brain injury by promoting M2 microglial\/macrophage polarization","volume":"47","author":"Jiang","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.bioactmat.2023.06.013_bib137","doi-asserted-by":"crossref","DOI":"10.1038\/srep44433","article-title":"White matter repair after extracellular vesicles administration in an experimental animal model of subcortical stroke","volume":"7","author":"Otero-Ortega","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioactmat.2023.06.013_bib138","doi-asserted-by":"crossref","first-page":"290","DOI":"10.3171\/2018.2.JNS171475","article-title":"Multipotent mesenchymal stromal cell-derived exosomes improve functional recovery after experimental intracerebral hemorrhage in the rat","volume":"131","author":"Han","year":"2019","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.bioactmat.2023.06.013_bib139","article-title":"Therapeutic potential of extracellular vesicles in preclinical stroke models: a systematic review and meta-analysis","volume":"4","author":"Thomas","year":"2020","journal-title":"BMJ Open Sci."},{"key":"10.1016\/j.bioactmat.2023.06.013_bib140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0069515","article-title":"Conditioned medium from bone marrow-derived mesenchymal stem cells improves recovery after spinal cord injury in rats: an original strategy to avoid cell transplantation","volume":"8","author":"Cantinieaux","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bioactmat.2023.06.013_bib141","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1089\/neu.2017.5201","article-title":"Effects of intrathecal injection of the conditioned medium from bone marrow stromal cells on spinal cord injury in rats","volume":"35","author":"Kanekiyo","year":"2018","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.bioactmat.2023.06.013_bib142","doi-asserted-by":"crossref","first-page":"785","DOI":"10.31616\/asj.2018.12.5.785","article-title":"Sensory and motor behavior evidences supporting the usefulness of conditioned medium from dental pulp-derived stem cells in spinal cord injury in rats","volume":"12","author":"Asadi-Golshan","year":"2018","journal-title":"Asian Spine J."},{"key":"10.1016\/j.bioactmat.2023.06.013_bib143","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19030870","article-title":"Localized intrathecal delivery of mesenchymal stromal cells conditioned medium improves functional recovery in a rat model of spinal cord injury","volume":"19","author":"Cizkova","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioactmat.2023.06.013_bib144","doi-asserted-by":"crossref","first-page":"684","DOI":"10.4149\/BLL_2018_123","article-title":"Evaluation of the effect of BMSCs condition media and methylprednisolone in TGF-beta expression and functional recovery after an acute spinal cord injury","volume":"119","author":"Khoshsirat","year":"2018","journal-title":"Bratislava Med. J.Bratislavske Lekarske Listy"},{"key":"10.1016\/j.bioactmat.2023.06.013_bib145","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20184516","article-title":"The effect of Wharton jelly-derived mesenchymal stromal cells and their conditioned media in the treatment of a rat spinal cord injury","volume":"20","author":"Chudickova","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioactmat.2023.06.013_bib146","article-title":"Attenuating spinal cord injury by conditioned medium from bone marrow mesenchymal stem cells","volume":"8","author":"Tsai","year":"2019","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.bioactmat.2023.06.013_bib147","doi-asserted-by":"crossref","DOI":"10.1186\/s13287-019-1491-7","article-title":"The superiority of conditioned medium derived from rapidly expanded mesenchymal stem cells for neural repair","volume":"10","author":"Chen","year":"2019","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.bioactmat.2023.06.013_bib148","doi-asserted-by":"crossref","first-page":"433","DOI":"10.22603\/ssrr.2022-0004","article-title":"Mesenchymal stem cell-conditioned medium promotes functional recovery following spinal cord injury: a systematic review and meta-analysis","volume":"6","author":"Sarveazad","year":"2022","journal-title":"Spine Surg. Relat. Res."},{"key":"10.1016\/j.bioactmat.2023.06.013_bib149","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/rheumatology\/kex278","article-title":"The process defines the product: what really matters in biosimilar design and production?","volume":"56","author":"Vulto","year":"2017","journal-title":"Rheumatology"},{"key":"10.1016\/j.bioactmat.2023.06.013_bib150","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.addr.2017.06.005","article-title":"Cells as advanced therapeutics: state-of-the-art, challenges, and opportunities in large scale biomanufacturing of high-quality cells for adoptive immunotherapies","volume":"114","author":"Dwarshuis","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.bioactmat.2023.06.013_bib151","first-page":"11","article-title":"Methodologies to isolate and purify clinical grade extracellular vesicles for medical applications","author":"Akbar","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.bioactmat.2023.06.013_bib152","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1016\/j.nano.2017.03.011","article-title":"Higher functionality of extracellular vesicles isolated using size-exclusion chromatography compared to ultracentrifugation","volume":"13","author":"Mol","year":"2017","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"10.1016\/j.bioactmat.2023.06.013_bib153","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21186466","article-title":"A review of exosomal isolation methods: is size exclusion chromatography the best option?","volume":"21","author":"Sidhom","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioactmat.2023.06.013_bib154","article-title":"Artificial exosomes for translational nanomedicine","volume":"19","author":"Li","year":"2021","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.bioactmat.2023.06.013_bib155","doi-asserted-by":"crossref","first-page":"7698","DOI":"10.1021\/nn402232g","article-title":"Bioinspired exosome-mimetic nanovesicles for targeted delivery of chemotherapeutics to malignant tumors","volume":"7","author":"Jang","year":"2013","journal-title":"ACS Nano"},{"key":"10.1016\/j.bioactmat.2023.06.013_bib156","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1080\/10717544.2020.1869866","article-title":"Preservation of small extracellular vesicles for functional analysis and therapeutic applications: a comparative evaluation of storage conditions","volume":"28","author":"Wu","year":"2021","journal-title":"Drug Deliv."},{"key":"10.1016\/j.bioactmat.2023.06.013_bib157","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.3390\/pharmaceutics13081129","article-title":"Freeze-dried mesenchymal stem cell-secretome pharmaceuticalization: optimization of formulation and manufacturing process robustness","volume":"13","author":"Mocchi","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.bioactmat.2023.06.013_bib158","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.00181","article-title":"Freeze-dried extracellular vesicles from adipose-derived stem cells prevent hypoxia-induced muscle cell injury","volume":"8","author":"El Baradie","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.bioactmat.2023.06.013_bib159","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2022.112745","article-title":"Efficient extracellular vesicles freeze-dry method for direct formulations preparation and use","volume":"218","author":"Guarro","year":"2022","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.bioactmat.2023.06.013_bib160","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202100538","article-title":"Enhancing the stabilization potential of lyophilization for extracellular vesicles","volume":"11","author":"Trenkenschuh","year":"2022","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.bioactmat.2023.06.013_bib161","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10051063","article-title":"Three-dimensional bioprinted controlled release scaffold containing mesenchymal stem\/stromal lyosecretome for bone regeneration: sterile manufacturing and in vitro biological efficacy","volume":"10","author":"Bari","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.bioactmat.2023.06.013_bib162","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22084064","article-title":"Biohybrid bovine bone matrix for controlled release of mesenchymal stem\/stromal cell lyosecretome: a device for bone regeneration","volume":"22","author":"Bari","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioactmat.2023.06.013_bib163","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22168445","article-title":"Freeze-dried secretome (lyosecretome) from mesenchymal stem\/stromal cells promotes the osteoinductive and osteoconductive properties of titanium cages","volume":"22","author":"Bari","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioactmat.2023.06.013_bib164","doi-asserted-by":"crossref","DOI":"10.3390\/ani11113271","article-title":"Canine mesenchymal cell lyosecretome production and safety evaluation after allogenic intraarticular injection in osteoarthritic dogs","volume":"11","author":"Mocchi","year":"2021","journal-title":"Animals"},{"key":"10.1016\/j.bioactmat.2023.06.013_bib165","doi-asserted-by":"crossref","DOI":"10.3390\/ph14040296","article-title":"When albumin meets liposomes: a feasible drug carrier for biomedical applications","volume":"14","author":"Taguchi","year":"2021","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.bioactmat.2023.06.013_bib166","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1208\/s12248-014-9598-3","article-title":"Understanding pharmaceutical quality by design","volume":"16","author":"Yu","year":"2014","journal-title":"AAPS J."},{"key":"10.1016\/j.bioactmat.2023.06.013_bib167","first-page":"315","article-title":"Minimal criteria for defining multipotent mesenchymal stromal cells","volume":"8","author":"Dominici","year":"2006","journal-title":"Int. Soc. Cell Ther. Position Statement, Cytother."},{"key":"10.1016\/j.bioactmat.2023.06.013_bib168","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1089\/scd.2014.0299","article-title":"Gism, ex vivo expanded mesenchymal stromal cell minimal quality requirements for clinical application","volume":"24","author":"Torre","year":"2015","journal-title":"Stem Cell. Dev."},{"key":"10.1016\/j.bioactmat.2023.06.013_bib169","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jcyt.2015.11.008","article-title":"International Society for Cellular Therapy perspective on immune functional assays for mesenchymal stromal cells as potency release criterion for advanced phase clinical trials","volume":"18","author":"Galipeau","year":"2016","journal-title":"Cytotherapy"},{"key":"10.1016\/j.bioactmat.2023.06.013_bib170","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.jcyt.2018.12.006","article-title":"Manufacturing and characterization of extracellular vesicles from umbilical cord-derived mesenchymal stromal cells for clinical testing","volume":"21","author":"Rohde","year":"2019","journal-title":"Cytotherapy"},{"key":"10.1016\/j.bioactmat.2023.06.013_bib171","doi-asserted-by":"crossref","DOI":"10.1080\/20013078.2018.1535750","article-title":"Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines","volume":"7","author":"Thery","year":"2018","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.bioactmat.2023.06.013_bib172","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12182","article-title":"Updating MISEV: evolving the minimal requirements for studies of extracellular vesicles","volume":"10","author":"Witwer","year":"2021","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.bioactmat.2023.06.013_bib173","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1002\/pmic.201200329","article-title":"Proteomics, transcriptomics and lipidomics of exosomes and ectosomes","volume":"13","author":"Choi","year":"2013","journal-title":"Proteomics"},{"key":"10.1016\/j.bioactmat.2023.06.013_bib174","first-page":"1","article-title":"Application of quality by design in the current drug development","volume":"12","author":"Zhang","year":"2017","journal-title":"Asian J. Pharm. Sci."},{"key":"10.1016\/j.bioactmat.2023.06.013_bib175","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12085","article-title":"Biodistribution of extracellular vesicles following administration into animals: a systematic review","volume":"10","author":"Kang","year":"2021","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.bioactmat.2023.06.013_bib176","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/nrd3079","article-title":"OUTLOOK Relative efficacy of drugs: an emerging issue between regulatory agencies and third-party payers","volume":"9","author":"Eichler","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bioactmat.2023.06.013_bib177","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.drudis.2012.01.021","article-title":"Health economics and outcomes research wiihin drug development challenges and opportunities for reimbursement and market access within biopharma research","volume":"17","author":"van Nooten","year":"2012","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.bioactmat.2023.06.013_bib178","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics10030116","article-title":"Tailoring formulations for intranasal nose-to-brain delivery: a review on architecture, physico-chemical characteristics and mucociliary clearance of the nasal olfactory mucosa","volume":"10","author":"Ganger","year":"2018","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.bioactmat.2023.06.013_bib179","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ejpb.2018.05.009","article-title":"Recent advances in carrier mediated nose-to-brain delivery of pharmaceutics","volume":"128","author":"Bourganis","year":"2018","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.bioactmat.2023.06.013_bib180","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/nrd4363","article-title":"Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies","volume":"13","author":"Mitragotri","year":"2014","journal-title":"Nat. Rev. Drug Discov."}],"container-title":["Bioactive Materials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452199X23001962?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452199X23001962?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T14:43:48Z","timestamp":1762785828000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452199X23001962"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":180,"alternative-id":["S2452199X23001962"],"URL":"https:\/\/doi.org\/10.1016\/j.bioactmat.2023.06.013","relation":{},"ISSN":["2452-199X"],"issn-type":[{"value":"2452-199X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mesenchymal stem cell secretome and extracellular vesicles for neurodegenerative diseases: Risk-benefit profile and next steps for the market access","name":"articletitle","label":"Article Title"},{"value":"Bioactive Materials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioactmat.2023.06.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd.","name":"copyright","label":"Copyright"}]}}